Let's go to the topic of local anaesthetic agents in the unit 3 of pharmacology of drug action on peripheral nervous system of semester 4 what are the things should I be studying in this topic what are the sub topics and other stuff related to that

Reading File
Finding Sources
Searching the Web

local anaesthetic agents pharmacology semester 4 syllabus topics subtopics

Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
I now have a thorough picture from Miller's Anesthesia (the gold-standard reference for this topic). Let me compile the complete study guide.
Here is your complete study guide for Local Anaesthetic Agents - Unit 3, Pharmacology of Peripheral Nervous System, Semester 4.

Local Anaesthetic Agents - Complete Study Guide


Overview

Local anaesthetics (LAs) are drugs that produce reversible loss of sensation in a localised region by blocking nerve impulse conduction, without loss of consciousness. This is a high-yield topic that spans basic science through clinical application.

1. Chemistry and Classification

The LA Molecule

Every classical LA has three parts:
  • Aromatic ring (lipophilic end, gives membrane affinity)
  • Intermediate chain - either an ester (-COO-) or amide (-NHCO-) linkage
  • Tertiary amine (hydrophilic end, partly protonated at physiologic pH)

Two Major Classes

FeatureAminoestersAminoamides
BondEsterAmide
ExamplesProcaine, Cocaine, Chloroprocaine, Tetracaine, BenzocaineLidocaine, Bupivacaine, Ropivacaine, Prilocaine, Mepivacaine, Levobupivacaine
MetabolismPlasma pseudocholinesterase (rapid)Hepatic microsomal enzymes (slower)
AllergyMore common (PABA derivative)Rare
StabilityLess stableMore stable

Physicochemical Properties to Know

  • pKa: Determines onset speed. Lower pKa = more unionised drug at pH 7.4 = faster onset (e.g. lidocaine pKa 7.7, chloroprocaine pKa 8.7)
  • Lipid solubility: Determines potency. More lipophilic = more potent (bupivacaine > lidocaine > procaine)
  • Protein binding: Determines duration. Higher protein binding = longer duration (bupivacaine ~95% protein bound)
  • pKa, lipid solubility, and protein binding are the three pillars of structure-activity relationships

2. Mechanism of Action

Physiology of Nerve Conduction (prerequisite)

  • Resting membrane potential: -60 to -90 mV
  • Na+/K+ ATPase maintains the gradient
  • Action potential is driven by rapid Na+ influx through voltage-gated Na+ channels (VGNCs)

How LAs Work (step by step)

  1. LA deposited near the nerve diffuses through the nerve sheath
  2. Unionised (base) form crosses the axonal membrane
  3. Inside the axoplasm, at lower pH, the drug re-ionises to the cationic (charged) form
  4. The cationic form binds to the intracellular face of voltage-gated Na+ channels
  5. This blocks channel opening (prevents activation/depolarisation)
  6. No action potential = no nerve conduction = anaesthesia

Key Concepts

  • Tonic (resting) block: Drug binds when channel is in resting state
  • Phasic (use-dependent) block: Repeated stimulation allows more drug to enter open channels; block deepens with activity
  • Ion trapping: In infected/inflamed tissue (acidic pH), more drug stays ionised outside the cell and cannot cross the membrane - this is why LAs work poorly in infected tissue

Na+ Channel Isoforms

  • Nav1.7, Nav1.8, Nav1.9 are key neuronal isoforms - mutations lead to congenital pain insensitivity or erythromelalgia (clinically relevant)

3. Differential Nerve Block (Order of Block)

Nerve fibres are blocked in a predictable order. Know this:
OrderFibre typeFunction lost
1stC fibres (small, unmyelinated)Pain and temperature
2ndB fibresPreganglionic autonomic
3rdA-delta fibresPain, cold, touch
4thA-gammaMuscle spindle tone
5thA-betaTouch, pressure, vibration
6thA-alpha (largest)Motor, proprioception (last to go)
Mnemonic: "Small before large" - pain disappears before motor power

4. Clinical Pharmacology

Factors Affecting LA Activity in Practice

FactorEffect
Concentration/doseHigher dose = denser block
Site of injectionEpidural > peripheral (more vascular = faster absorption = shorter duration)
Addition of vasoconstrictor (epinephrine)Reduces absorption, prolongs duration, decreases systemic toxicity
Carbonation/pH adjustment (NaHCO3)Increases unionised fraction, speeds onset
PregnancyEnhanced sensitivity (progesterone lowers threshold)
Inflammation/infectionReduces efficacy (acidic environment)

Vasoconstrictors as Additives

  • Epinephrine (most common): 1:200,000 concentration; prolongs block, reduces peak plasma concentration
  • Clonidine/Dexmedetomidine: Alpha-2 agonists, prolong block
  • Dexamethasone: Prolongs duration (mechanism: anti-inflammatory + direct neuronal effect)
  • Buprenorphine: Opioid additive, prolongs analgesia

Specific Drugs to Know

DrugClassOnsetDurationKey Feature
Lidocaine (Lignocaine)AmideFastMedium (1-2h)Most versatile, antiarrhythmic
BupivacaineAmideSlowLong (4-8h)High cardiotoxicity risk
RopivacaineAmideModerateLongLess cardiotoxic than bupivacaine, more motor-sparing
LevobupivacaineAmideModerateLongS-enantiomer of bupivacaine, safer than racemic
ProcaineEsterSlowShortPrototype ester
CocaineEsterFastMediumOnly LA with vasoconstrictor effect; ENT use only
Tetracaine (Amethocaine)EsterSlowLongSpinal & topical use
PrilocaineAmideFastMediumMethemoglobinemia risk
BenzocaineEsterFastShortTopical only (insoluble in water); methemoglobinemia

5. Routes and Types of Regional Anaesthesia

  • Infiltration anaesthesia: Subcutaneous injection at the surgical site
  • Topical/surface anaesthesia: EMLA cream (lidocaine + prilocaine), throat spray
  • Nerve block: Single nerve (ulnar, radial) or major plexus (brachial plexus)
  • IV Regional Anaesthesia (Bier's block): IV LA into exsanguinated, tourniquet-isolated limb; lidocaine used
  • Spinal (intrathecal) anaesthesia: Injected into CSF (subarachnoid space); bupivacaine/tetracaine
  • Epidural anaesthesia: Injected into epidural space; bupivacaine/ropivacaine
  • Tumescent anaesthesia: Large volumes of dilute LA + epinephrine + NaHCO3 (used in liposuction)

6. Pharmacokinetics

  • Absorption: Depends on site, vascularity, drug properties, and use of vasoconstrictors. Order: IV > tracheal > intercostal > caudal > epidural > brachial plexus > subcutaneous
  • Distribution: Highly bound to alpha-1-acid glycoprotein (AAG) and albumin in plasma
  • Metabolism:
    • Esters: Rapid hydrolysis by plasma pseudocholinesterase (to PABA in some)
    • Amides: Hepatic cytochrome P450 (slower; accumulate in liver disease)
  • Excretion: Renal (metabolites)

7. Toxicity (High-Yield!)

Systemic Toxicity (LAST - Local Anaesthetic Systemic Toxicity)

CNS Toxicity (occurs at lower blood levels than CVS):
  • Early: perioral tingling, metallic taste, tinnitus, lightheadedness, visual/auditory disturbance
  • Progressive: disorientation, drowsiness, muscular twitching
  • Severe: tonic-clonic seizures
  • Very severe: CNS depression, respiratory arrest
Cardiovascular Toxicity (requires higher blood levels):
  • Myocardial depression, bradycardia, conduction block
  • Hypotension, ventricular arrhythmias, cardiac arrest
  • Bupivacaine is the most cardiotoxic - causes "3 Cs": reentrant arrhythmias, cardiac depression, cardiovascular collapse
  • Bupivacaine cardiotoxicity difficult to treat; may require Intralipid (lipid emulsion rescue)
Treatment of LAST:
  • Stop injection, call for help
  • Airway/O2/ventilation (prevent acidosis - worsens toxicity)
  • Benzodiazepine or propofol for seizures
  • 20% Intralipid emulsion IV (lipid sink - sequesters LA from cardiac tissue)
  • CPR if needed; avoid vasopressin and Ca2+ channel blockers

Specific Adverse Effects

DrugSpecific toxicity
PrilocaineMethemoglobinemia (metabolite o-toluidine oxidises Hb); treat with methylene blue
BenzocaineMethemoglobinemia
Aminoesters (procaine)Allergic reactions (IgE-mediated; PABA metabolite)
CocaineCardiovascular stimulation, addiction, vasoconstriction
BupivacaineSevere, refractory cardiotoxicity

Local Tissue Toxicity

  • All LAs are neurotoxic at high concentrations in direct contact with nerve (transient neurological symptoms with spinal lidocaine)
  • Myotoxicity possible with direct muscle injection

8. Special Topics

Chiral LAs

  • Bupivacaine is a racemic mixture (R+S enantiomers)
  • Ropivacaine and levobupivacaine are pure S(-) enantiomers
  • S-enantiomers have lower cardiac toxicity than the R(+) form
  • This is the basis for preferring ropivacaine/levobupivacaine over bupivacaine when prolonged block is needed

Why LAs Fail in Infection

  • Infected tissue is acidic (low pH)
  • At low pH, more drug remains in ionised (cationic) form
  • Ionised form cannot cross the lipid membrane to reach the binding site
  • Result: poor block

Cocaine - Unique Properties

  • The only LA that causes vasoconstriction (blocks norepinephrine reuptake)
  • Used in ENT (nasal surgeries) as both LA + vasoconstrictor
  • Has abuse potential; not used for injection anaesthesia

9. Key High-Yield One-Liners to Memorise

  1. LAs block Na+ channels from the inside (intracellular face) in the ionised form
  2. They cross membranes in the unionised (base) form
  3. Lower pKa = faster onset
  4. Higher lipid solubility = greater potency
  5. Higher protein binding = longer duration
  6. Esters metabolised by plasma cholinesterase; amides by liver
  7. Prilocaine causes methemoglobinemia
  8. Bupivacaine has the highest cardiotoxicity
  9. Treat LAST with 20% intralipid
  10. Epinephrine prolongs block by local vasoconstriction (reduces vascular absorption)
  11. LAs fail in infection because of ion trapping
  12. Differential block order: pain first, motor last

10. Likely Exam Questions (Semester 4 Level)

  • Classify local anaesthetics with examples
  • Mechanism of action of local anaesthetics
  • Differences between ester and amide local anaesthetics
  • Factors determining onset, potency, and duration
  • Why does adrenaline prolong local anaesthesia?
  • Why do LAs fail in infected tissue?
  • Systemic toxicity of local anaesthetics - signs and management
  • Methemoglobinemia - which drugs cause it and how is it treated?
  • Bupivacaine vs. lidocaine - comparison
  • Cocaine - unique pharmacological properties
  • Order of nerve fibre susceptibility to LAs

Sources: Miller's Anesthesia 10th Edition (Ch. 25); Morgan & Mikhail's Clinical Anesthesiology 7e
This is a shared conversation. Sign in to Orris to start your own chat.